FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

William Hiatt

Research Profile

Disorders

Procedures

Anatomy

Physiology

Oxygen Consumption

Concepts & Ideas

Activities & Behaviors

Chemicals & Drugs

Geographic Areas

United States

Co-author Network

Publications

TOP 3
Satish K Garg; William R Hiatt; Leslie J Klaff; Emily G Moser; Christie Beatson; Bruce W Bode; Janet Snell-Bergeon
Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial.
William R Hiatt; Allison B Goldfine; Sanjay Kaul
Cardiovascular risk assessment in the development of new drugs for obesity.
Sumeet Subherwal; Kevin J Anstrom; Michael S Conte; Michael G Felker; William R Hiatt; William S Jones; Sanjay Misra; Manesh R Patel
Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of William Hiatt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Satish K Garg; William R Hiatt; Leslie J Klaff; Emily G Moser; Christie Beatson; Bruce W Bode; Janet Snell-Bergeon
Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2013;19(1):19-28.
2012: William R Hiatt; Allison B Goldfine; Sanjay Kaul
Cardiovascular risk assessment in the development of new drugs for obesity.
JAMA : the journal of the American Medical Association 2012;308(11):1099-100.
2012: Sumeet Subherwal; Kevin J Anstrom; Michael S Conte; Michael G Felker; William R Hiatt; William S Jones; Sanjay Misra; Manesh R Patel
Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia.
American heart journal 2012;164(3):277-84.
2012: David P Kao; William R Hiatt; Mori J Krantz
Proarrhythmic potential of dronedarone: emerging evidence from spontaneous adverse event reporting.
Pharmacotherapy 2012;32(8):767-71.
2012: Jeffrey S Berger; William R Hiatt
Medical therapy in peripheral artery disease.
Circulation 2012;126(4):491-500.
2012: Neil A Goldenberg; Mori J Krantz; William R Hiatt
L-Carnitine plus cilostazol versus cilostazol alone for the treatment of claudication in patients with peripheral artery disease: a multicenter, randomized, double-blind, placebo-controlled trial.
Vascular medicine (London, England) 2012;17(3):145-54.
2012: W Schuyler Jones; William E Kraus; Judith G Regensteiner; Jennifer L Robbins; Ayotunde O Dokun; Natasha N Duggan; Brian D Duscha; William R Hiatt; Brian H Annex
Alteration in angiogenic and anti-angiogenic forms of vascular endothelial growth factor-A in skeletal muscle of patients with intermittent claudication following exercise training.
Vascular medicine (London, England) 2012;17(2):94-100.
2012: William R Hiatt; Abraham Thomas; Allison B Goldfine
What cost weight loss?
Circulation 2012;125(9):1171-7.
2012: Emile R Mohler; Warner Bundens; Julie Denenberg; William R Hiatt; Elizabeth Medenilla; Michael H Criqui
Progression of asymptomatic peripheral artery disease over 1 year.
Vascular medicine (London, England) 2012;17(1):10-6.
2011: Brian D Duscha; William R Hiatt; William S Jones; William E Kraus; R John Lye; Judith G Regensteiner; Jennifer L Robbins; John M Sanders; Jason D Allen; Brian H Annex
Angiogenesis in skeletal muscle precede improvements in peak oxygen uptake in peripheral artery disease patients.
Arteriosclerosis, thrombosis, and vascular biology 2011;31(11):2742-8.
2011: William R Hiatt
Commentary. The fate of the claudicant--a prospective study of 1969 claudicants.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2011;42 Suppl 1():S7-8.
2011: Jennifer L Robbins; Jason D Allen; Brian D Duscha; William R Hiatt; W Schuyler Jones; William E Kraus; Judith G Regensteiner; Brian H Annex
Relationship between leg muscle capillary density and peak hyperemic blood flow with endurance capacity in peripheral artery disease.
Journal of applied physiology (Bethesda, Md. : 1985) 2011;111(1):81-6.
2011: Bryan P Yan; James Y Lau; Check-Man Yu; Kim Au; Ka-Wai Chan; Doris S Yu; Ronald C Ma; Yat-Yin Lam; William R Hiatt
Chinese translation and validation of the Walking Impairment Questionnaire in patients with peripheral artery disease.
Vascular medicine (London, England) 2011;16(3):167-72.
2011: Ryan J Mays; Ivan P Casserly; Wendy M Kohrt; P Michael Ho; William R Hiatt; Mark R Nehler; Judith G Regensteiner
Assessment of functional status and quality of life in claudication.
Journal of vascular surgery 2011;53(5):1410-21.
2011: Neil A Goldenberg; Alex C Spyropoulos; Jonathan L Halperin; Craig M Kessler; Sam Schulman; Alexander G G Turpie; Allan M Skene; Neal R Cutler; William R Hiatt
Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model.
Blood 2011;117(7):2089-92.
2010: Gregorio Brevetti; Giuseppe Giugliano; Linda Brevetti; William R Hiatt
Inflammation in peripheral artery disease.
Circulation 2010;122(18):1862-75.
2010: Lars Norgren; William R Hiatt; John Dormandy; Alan T Hirsch; M R Jaff; C Diehm; I Baumgartner; J J F Belch
The next 10 years in the management of peripheral artery disease: perspectives from the 'PAD 2009' Conference.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2010;40(3):375-80.
2010: William R Hiatt; Alan T Hirsch; Mark A Creager; Sanjay Rajagopalan; Emile R Mohler; Christie M Ballantyne; Judith G Regensteiner; Diane Treat-Jacobson; Rita A Dale; Thom Rooke
Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral artery disease.
Vascular medicine (London, England) 2010;15(3):171-9.
2009: Alap P Shah; Andrew J Klein; Andrew Sterrett; John C Messenger; Stephen Albert; Mark R Nehler; William R Hiatt; Ivan P Casserly
Clinical outcomes using aggressive approach to anatomic screening and endovascular revascularization in a veterans affairs population with critical limb ischemia.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2009;74(1):11-9.
2008: Michael R Bristow; William R Hiatt
The FDA regulatory process for drug and genetic diagnostic test approvals.
Clinical and translational science 2008;1(3):188-9.
2008: William R Hiatt
Can measuring the ankle-brachial index improve public health?
Journal of the American College of Cardiology 2008;52(21):1743-4.
2008: William R Hiatt; A Michael Lincoff; Robert A Harrington
Acute pharmacological conversion of atrial fibrillation to sinus rhythm: is short-term symptomatic therapy worth it? A report from the December 2007 Meeting of the Cardiovascular and Renal Drugs Advisory Committee of the Food and Drug Administration.
Circulation 2008;117(22):2956-7.
2008: Carlos A Rueda; Mark R Nehler; Darryl J Perry; Robert B McLafferty; Ivan P Casserly; William R Hiatt; Brian D Peyton
Patterns of artery disease in 450 patients undergoing revascularization for critical limb ischemia: implications for clinical trial design.
Journal of vascular surgery 2008;47(5):995-9; discussion 999-1000.
2008: Judith G Regensteiner; William R Hiatt; Joseph R Coll; Michael H Criqui; Diane Treat-Jacobson; Mary M McDermott; Alan T Hirsch
The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program.
Vascular medicine (London, England) 2008;13(1):15-24.
2008: William R Hiatt; Samuel R Money; Eric P Brass
Long-term safety of cilostazol in patients with peripheral artery disease: the CASTLE study (Cilostazol: A Study in Long-term Effects).
Journal of vascular surgery 2008;47(2):330-336.
2008: J Chung; Eric P Brass; Roger G Ulrich; William R Hiatt
Effect of atorvastatin on energy expenditure and skeletal muscle oxidative metabolism at rest and during exercise.
Clinical pharmacology and therapeutics 2008;83(2):243-50.
2008: William R Hiatt
Aspirin for prevention of cardiovascular events.
BMJ (Clinical research ed.) 2008;337():a1806.
2007: Scott Haugen; Ivan P Casserly; Judith G Regensteiner; William R Hiatt
Risk assessment in the patient with established peripheral arterial disease.
Vascular medicine (London, England) 2007;12(4):343-50.
2007: Robert G Mitchell; Brian D Duscha; Jennifer L Robbins; Shelley I Redfern; Jayer Chung; Daniel R Bensimhon; William E Kraus; William R Hiatt; Judith G Regensteiner; Brian H Annex
Increased levels of apoptosis in gastrocnemius skeletal muscle in patients with peripheral arterial disease.
Vascular medicine (London, England) 2007;12(4):285-90.
2007: Lars Norgren; William R Hiatt; Kenneth A Harris; Johannes Lammer
TASC II section F on revascularization in PAD.
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2007;14(5):743-4.
2007: Robert W Schrier; Raymond O Estacio; Philip S Mehler; William R Hiatt
Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial.
Nature clinical practice. Nephrology 2007;3(8):428-38.
2007: L Norgren; William R Hiatt; John Dormandy; Mark R Nehler; KA Harris; F Gerald R Fowkes; Robert B Rutherford
Inter-society consensus for the management of peripheral arterial disease.
International angiology : a journal of the International Union of Angiology 2007;26(2):81-157.
2007: Mark R Nehler; Eric P Brass; Richard Anthony; John Dormandy; Jenny Jiao; Thomas O McNamara; William R Hiatt
Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes.
Journal of vascular surgery 2007;45(5):953-60; discussion 960-1.
2007: Timothy A Bauer; Eric P Brass; Thomas J Barstow; William R Hiatt
Skeletal muscle StO2 kinetics are slowed during low work rate calf exercise in peripheral arterial disease.
European journal of applied physiology 2007;100(2):143-51.
2007: L Norgren; William R Hiatt; John Dormandy; Mark R Nehler; KA Harris; F Gerald R Fowkes
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
Journal of vascular surgery 2007;45 Suppl S():S5-67.
2007: L Norgren; William R Hiatt; John Dormandy; Mark R Nehler; KA Harris; F Gerald R Fowkes; Kevin Bell; Joseph Caporusso; Isabelle Durand-Zaleski; Kimihiro Komori; Johannes Lammer; Christos Liapis; Salvatore Novo; Mahmood Razavi; Johns Robbs; Nicholaas Schaper; Hiroshi Shigematsu; Marc Sapoval; Christopher White; John White; Denis Clement; Mark Creager; Michael Jaff; Emile Mohler; Robert B Rutherford; Peter Sheehan; Henrik Sillesen; Kenneth Rosenfield
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2007;33 Suppl 1():S1-75.
2006: Eric P Brass; Richard Anthony; Frederick R Cobb; Isao Koda; Jenny Jiao; William R Hiatt
The novel phosphodiesterase inhibitor NM-702 improves claudication-limited exercise performance in patients with peripheral arterial disease.
Journal of the American College of Cardiology 2006;48(12):2539-45.
2006: William R Hiatt
Observational studies of drug safety--aprotinin and the absence of transparency.
The New England journal of medicine 2006;355(21):2171-3.
2006: Jayer Chung; Becki B Bartelson; William R Hiatt; Brian D Peyton; Robert B McLafferty; Charles W Hopley; Kelli D Salter; Mark R Nehler
Wound healing and functional outcomes after infrainguinal bypass with reversed saphenous vein for critical limb ischemia.
Journal of vascular surgery 2006;43(6):1183-90.
2006: Eric P Brass; Richard Anthony; John Dormandy; William R Hiatt; Jenny Jiao; Atsushi Nakanishi; Thomas McNamara; Mark R Nehler
Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia.
Journal of vascular surgery 2006;43(4):752-9.
2006: William R Hiatt; Steven E Nissen
New drug application 21-628, Certican (everolimus), for the proposed indication of prophylaxis of rejection in heart transplantation: report from the Cardiovascular and Renal Drugs Advisory Committee, US Food and Drug Administration, November 16, 2005, Rockville, Md.
Circulation 2006;113(10):e394-5.
2006: Eric P Brass; Roger J Lewis; Raymond Lipicky; James Murphy; William R Hiatt
Risk assessment in drug development for symptomatic indications: a framework for the prospective exclusion of unacceptable cardiovascular risk.
Clinical pharmacology and therapeutics 2006;79(3):165-72.
2006: William R Hiatt; Mori J Krantz
Masterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudication.
Vascular medicine (London, England) 2006;11(1):55-60.
2005: William R Hiatt
The US experience with cilostazol in treating intermittent claudication.
Atherosclerosis. Supplements 2005;6(4):21-31.
2005: Philip S Mehler; Mori J Krantz; Rita A Lundgren; Raymond O Estacio; Thomas D MacKenzie; Laurel Petralia; William R Hiatt
Bridging the quality gap in diabetic hyperlipidemia: a practice-based intervention.
The American journal of medicine 2005;118(12):1414.
2005: William R Hiatt; Lisa Cox; Marilyn Greenwalt; Ali Griffin; Cynthia Schechter
Quality of the assessment of primary and secondary endpoints in claudication and critical leg ischemia trials.
Vascular medicine (London, England) 2005;10(3):207-13.
2004: William R Hiatt; Ellen Klepack; Mark R Nehler; Judith G Regensteiner; John Blue; James Imus; Michael H Criqui
The effect of inhibition of acyl coenzyme A-cholesterol acyltransferase (ACAT) on exercise performance in patients with peripheral arterial disease.
Vascular medicine (London, England) 2004;9(4):271-7.
2004: Emile R Mohler; Diane Treat-Jacobson; Muredach P Reilly; Kelly E Cunningham; Mark Miani; Michael H Criqui; William R Hiatt; Alan T Hirsch
Utility and barriers to performance of the ankle-brachial index in primary care practice.
Vascular medicine (London, England) 2004;9(4):253-60.
2004: William R Hiatt
Carnitine and peripheral arterial disease.
Annals of the New York Academy of Sciences 2004;1033():92-8.
2004: William R Hiatt
Treatment of disability in peripheral arterial disease: new drugs.
Current drug targets. Cardiovascular & haematological disorders 2004;4(3):227-31.
2004: Timothy A Bauer; Eric P Brass; William R Hiatt
Impaired muscle oxygen use at onset of exercise in peripheral arterial disease.
Journal of vascular surgery 2004;40(3):488-93.
2004: Timothy A Bauer; Eric P Brass; Mark R Nehler; Thomas J Barstow; William R Hiatt
Pulmonary VO2 dynamics during treadmill and arm exercise in peripheral arterial disease.
Journal of applied physiology (Bethesda, Md. : 1985) 2004;97(2):627-34.
2004: William R Hiatt; Alan T Hirsch; john cooke; Jeffrey W Olin; D Craig Brater; Mark A Creager
Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacy.
Vascular medicine (London, England) 2004;9(1):18-25.
2003: Emile R Mohler; William R Hiatt; Mark A Creager
Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease.
Circulation 2003;108(12):1481-6.
2003: Mark R Nehler; Joseph R Coll; William R Hiatt; Judith G Regensteiner; Gabriel T Schnickel; William A Klenke; Pam K Strecker; Michelle W Anderson; Darrell N Jones; Thomas A Whitehill; Shevie Moskowitz; William C Krupski
Functional outcome in a contemporary series of major lower extremity amputations.
Journal of vascular surgery 2003;38(1):7-14.
2003: Emile R Mohler; William R Hiatt; Jeffrey W Olin; Michael Wade; Roger Jeffs; Alan T Hirsch
Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial.
Journal of the American College of Cardiology 2003;41(10):1679-86.
2003: Rita A Falcone; Alan T Hirsch; Judith G Regensteiner; Diane Treat-Jacobson; Mark A Williams; William R Hiatt; Kerry Stewart
Peripheral arterial disease rehabilitation: a review.
Journal of cardiopulmonary rehabilitation 2003;23(3):170-5.
2003: Philip S Mehler; Anne Esler; Raymond O Estacio; Thomas D MacKenzie; William R Hiatt; Robert W Schrier
Lack of improvement in the treatment of hyperlipidemia among patients with type 2 diabetes.
The American journal of medicine 2003;114(5):377-82.
2003: Philip S Mehler; Joseph R Coll; Raymond O Estacio; Anne Esler; Robert W Schrier; William R Hiatt
Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes.
Circulation 2003;107(5):753-6.
2002: Kerry Stewart; William R Hiatt; Judith G Regensteiner; Alan T Hirsch
Exercise training for claudication.
The New England journal of medicine 2002;347(24):1941-51.
2002: Judith G Regensteiner; John Ware; Walter J McCarthy; Peter Zhang; William P Forbes; Jeffrey Heckman; William R Hiatt
Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials.
Journal of the American Geriatrics Society 2002;50(12):1939-46.
2002: William R Hiatt
Pharmacologic therapy for peripheral arterial disease and claudication.
Journal of vascular surgery 2002;36(6):1283-91.
2002: Carolyn J Swenson; Mary Jo Trepka; Marian Rewers; Sharon Scarbro; William R Hiatt; Richard Hamman
Cardiovascular disease mortality in Hispanics and non-Hispanic whites.
American journal of epidemiology 2002;156(10):919-28.
2002: Eric P Brass; Sharon Adler; Kathy E Sietsema; Antonino Amato; Anne Esler; William R Hiatt
Peripheral arterial disease is not associated with an increased prevalence of intradialytic cramps in patients on maintenance hemodialysis.
American journal of nephrology 2002;22(5-6):491-6.
2002: William R Hiatt
Abciximab added to urokinase increased amputation-free survival in peripheral arterial occlusion of the legs.
ACP journal club 2002;137(1):12.
2002: William R Hiatt
Preventing atherothrombotic events in peripheral arterial disease: the use of antiplatelet therapy.
Journal of internal medicine 2002;251(3):193-206.
2002: Judith G Regensteiner; William R Hiatt
Treatment of peripheral arterial disease.
Clinical cornerstone 2002;4(5):26-40.
2002: Judith G Regensteiner; William R Hiatt
Current medical therapies for patients with peripheral arterial disease: a critical review.
The American journal of medicine 2002;112(1):49-57.
2002: Kathy E Sietsema; William R Hiatt; Anne Esler; Sharon Adler; Antonino Amato; Eric P Brass
Clinical and demographic predictors of exercise capacity in end-stage renal disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;39(1):76-85.
2001: Leslie T Cooper; William R Hiatt; Mark A Creager; Judith G Regensteiner; W Casscells; J M Isner; john cooke; Alan T Hirsch
Proteinuria in a placebo-controlled study of basic fibroblast growth factor for intermittent claudication.
Vascular medicine (London, England) 2001;6(4):235-9.
2001: Alan T Hirsch; Michael H Criqui; Diane Treat-Jacobson; Judith G Regensteiner; Mark A Creager; J W Olin; S H Krook; Donald B Hunninghake; A J Comerota; M E Walsh; M M McDermott; William R Hiatt
Peripheral arterial disease detection, awareness, and treatment in primary care.
JAMA : the journal of the American Medical Association 2001;286(11):1317-24.
2001: William R Hiatt; Judith G Regensteiner; Mark A Creager; Alan T Hirsch; john cooke; J W Olin; G N Gorbunov; J Isner; Y V Lukjanov; M S Tsitsiashvili; T F Zabelskaya; A Amato
Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication.
The American journal of medicine 2001;110(8):616-22.
2001: William R Hiatt
Medical treatment of peripheral arterial disease and claudication.
The New England journal of medicine 2001;344(21):1608-21.
2001: Philip S Mehler; J Y Scott; I Pines; N Gifford; SL Biggerstaff; William R Hiatt
Russian immigrant cardiovascular risk assessment.
Journal of health care for the poor and underserved 2001;12(2):224-35.
2001: Eric P Brass; Sharon Adler; Kathy E Sietsema; William R Hiatt; A M Orlando; Antonino Amato
Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;37(5):1018-28.
2001: William R Hiatt
New treatment options in intermittent claudication: the US experience.
International journal of clinical practice. Supplement 2001;(119):20-7.
2001: William R Hiatt; Mark R Nehler
Peripheral arterial disease.
Advances in internal medicine 2001;47():89-110.
2001: Alan T Hirsch; William R Hiatt
PAD awareness, risk, and treatment: new resources for survival--the USA PARTNERS program.
Vascular medicine (London, England) 2001;6(3 Suppl):9-12.
2000: David L Dawson; BS Cutler; William R Hiatt; R W Hobson; J D Martin; EB Bortey; William P Forbes; D Eugene Strandness
A comparison of cilostazol and pentoxifylline for treating intermittent claudication.
The American journal of medicine 2000;109(7):523-30.
2000: William R Hiatt
Regarding: "Expression of myosin heavy chain isoforms in skeletal muscle of patients with peripheral arterial occlusive disease".
Journal of vascular surgery 2000;31(3):611-2.
2000: Eric P Brass; H Wang; William R Hiatt
Multiple skeletal muscle mitochondrial DNA deletions in patients with unilateral peripheral arterial disease.
Vascular medicine (London, England) 2000;5(4):225-30.
2000: Eric P Brass; William R Hiatt
Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease.
Vascular medicine (London, England) 2000;5(1):55-9.
2000: William C Krupski; Mark R Nehler; Thomas A Whitehill; R C Lawson; Pam K Strecker; William R Hiatt
Negative impact of cardiac evaluation before vascular surgery.
Vascular medicine (London, England) 2000;5(1):3-9.
1999: William R Hiatt
Functional assessment of the claudicant importance of treatment and follow-up strategies.
Minerva cardioangiologica 1999;47(11):385-6.
1999: Suzanne L Brandenburg; Jane E B Reusch; Timothy A Bauer; BW Jeffers; William R Hiatt; Judith G Regensteiner
Effects of exercise training on oxygen uptake kinetic responses in women with type 2 diabetes.
Diabetes care 1999;22(10):1640-6.
1999: Mark R Nehler; Thomas A Whitehill; S P Bowers; Darrell N Jones; William R Hiatt; Robert B Rutherford; William C Krupski
Intermediate-term outcome of primary digit amputations in patients with diabetes mellitus who have forefoot sepsis requiring hospitalization and presumed adequate circulatory status.
Journal of vascular surgery 1999;30(3):509-17.
1999: Timothy A Bauer; Judith G Regensteiner; Eric P Brass; William R Hiatt
Oxygen uptake kinetics during exercise are slowed in patients with peripheral arterial disease.
Journal of applied physiology (Bethesda, Md. : 1985) 1999;87(2):809-16.
1999: H Wang; William R Hiatt; Thomas J Barstow; Eric P Brass
Relationships between muscle mitochondrial DNA content, mitochondrial enzyme activity and oxidative capacity in man: alterations with disease.
European journal of applied physiology and occupational physiology 1999;80(1):22-7.
1999: H K Bhat; William R Hiatt; C L Hoppel; Eric P Brass
Skeletal muscle mitochondrial DNA injury in patients with unilateral peripheral arterial disease.
Circulation 1999;99(6):807-12.
1999: Mark R Nehler; William R Hiatt
Exercise therapy for claudication.
Annals of vascular surgery 1999;13(1):109-14.
1998: Judith G Regensteiner; Timothy A Bauer; Jane E B Reusch; Suzanne L Brandenburg; Jeffrey M Sippel; A M Vogelsong; S Smith; Eugene E Wolfel; Robert H Eckel; William R Hiatt
Abnormal oxygen uptake kinetic responses in women with type II diabetes mellitus.
Journal of applied physiology (Bethesda, Md. : 1985) 1998;85(1):310-7.
1998: Eric P Brass; William R Hiatt
The role of carnitine and carnitine supplementation during exercise in man and in individuals with special needs.
Journal of the American College of Nutrition 1998;17(3):207-15.
1998: S A Scherer; J S Bainbridge; William R Hiatt; Judith G Regensteiner
Gait characteristics of patients with claudication.
Archives of physical medicine and rehabilitation 1998;79(5):529-31.
1998: Raymond O Estacio; BW Jeffers; William R Hiatt; SL Biggerstaff; N Gifford; Robert W Schrier
The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
The New England journal of medicine 1998;338(10):645-52.
1997: Judith G Regensteiner; T J Meyer; W C Krupski; L S Cranford; William R Hiatt
Hospital vs home-based exercise rehabilitation for patients with peripheral arterial occlusive disease.
Angiology 1997;48(4):291-300.
1997: William R Hiatt
Current and future drug therapies for claudication.
Vascular medicine (London, England) 1997;2(3):257-62.
1997: Judith G Regensteiner; A Gardner; William R Hiatt
Exercise testing and exercise rehabilitation for patients with peripheral arterial disease: status in 1997.
Vascular medicine (London, England) 1997;2(2):147-55.
1996: William R Hiatt; Judith G Regensteiner; Eugene E Wolfel; M R Carry; E P Brass
Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease.
Journal of applied physiology (Bethesda, Md. : 1985) 1996;81(2):780-8.
1996: William R Hiatt; M A Creager; john cooke; Alan T Hirsch
Building a partnership between vascular medicine and vascular surgery: a coalition for the future of vascular care.
Journal of vascular surgery 1996;23(5):918-25.
1996: Alan T Hirsch; G Haidet; M A Creager; William R Hiatt; Judith G Regensteiner; john cooke
Exercise rehabilitation for treatment of claudication.
JAMA : the journal of the American Medical Association 1996;275(7):519-20.
1996: Judith G Regensteiner; John F Steiner; William R Hiatt
Exercise training improves functional status in patients with peripheral arterial disease.
Journal of vascular surgery 1996;23(1):104-15.
1995: William R Hiatt; Alan T Hirsch; Judith G Regensteiner; E P Brass
Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists.
Circulation 1995;92(3):614-21.
1995: Judith G Regensteiner; J Sippel; E T McFarling; Eugene E Wolfel; William R Hiatt
Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise.
Medicine and science in sports and exercise 1995;27(6):875-81.
1995: Judith G Regensteiner; J Sippel; E T McFarling; Eugene E Wolfel; William R Hiatt
Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise.
Medicine and science in sports and exercise 1995;27(5):661-7.
1995: William R Hiatt; S Hoag; Richard Hamman
Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study.
Circulation 1995;91(5):1472-9.
1995: Judith G Regensteiner; William R Hiatt
Exercise rehabilitation for patients with peripheral arterial disease.
Exercise and sport sciences reviews 1995;23():1-24.
1994: William R Hiatt; Eugene E Wolfel; R H Meier; Judith G Regensteiner
Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response.
Circulation 1994;90(4):1866-74.
1994: Judith G Regensteiner; William R Hiatt
Medical management of peripheral arterial disease.
Journal of vascular and interventional radiology : JVIR 1994;5(5):669-77.
1993: William R Hiatt; Judith G Regensteiner; Eugene E Wolfel
Special populations in cardiovascular rehabilitation. Peripheral arterial disease, non-insulin-dependent diabetes mellitus, and heart failure.
Cardiology clinics 1993;11(2):309-21.
1993: Judith G Regensteiner; Eugene E Wolfel; E P Brass; M R Carry; Steven P Ringel; M E Hargarten; E R Stamm; William R Hiatt
Chronic changes in skeletal muscle histology and function in peripheral arterial disease.
Circulation 1993;87(2):413-21.
1993: Judith G Regensteiner; M E Hargarten; Robert B Rutherford; William R Hiatt
Functional benefits of peripheral vascular bypass surgery for patients with intermittent claudication.
Angiology 1993;44(1):1-10.
1992: William R Hiatt
Contemporary treatment of venous lower limb ulcers.
Angiology 1992;43(10):852-5.
1992: William R Hiatt; Eugene E Wolfel; Judith G Regensteiner; E P Brass
Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease.
Journal of applied physiology (Bethesda, Md. : 1985) 1992;73(1):346-53.
1992: William R Hiatt; B J Koziol; Joseph Shapiro; E P Brass
Carnitine metabolism during exercise in patients on chronic hemodialysis.
Kidney international 1992;41(6):1613-9.
1992: John D England; Judith G Regensteiner; Steven P Ringel; M R Carry; William R Hiatt
Muscle denervation in peripheral arterial disease.
Neurology 1992;42(5):994-9.
1990: William R Hiatt; Judith G Regensteiner; M E Hargarten; Eugene E Wolfel; E P Brass
Benefit of exercise conditioning for patients with peripheral arterial disease.
Circulation 1990;81(2):602-9.
1990: Eugene E Wolfel; William R Hiatt; H L Brammell; V Travis; Lawrence D Horwitz
Plasma catecholamine responses to exercise after training with beta-adrenergic blockade.
Journal of applied physiology (Bethesda, Md. : 1985) 1990;68(2):586-93.
1990: William R Hiatt; J A Marshall; J Baxter; R Sandoval; W Hildebrandt; L R Kahn; Richard Hamman
Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study.
Journal of clinical epidemiology 1990;43(6):597-606.
1989: William R Hiatt; Judith G Regensteiner; Eugene E Wolfel; L Ruff; E P Brass
Carnitine and acylcarnitine metabolism during exercise in humans. Dependence on skeletal muscle metabolic state.
The Journal of clinical investigation 1989;84(4):1167-73.
1989: William R Hiatt; S Y Huang; Judith G Regensteiner; A J Micco; G Ishimoto; M Manco-Johnson; J Drose; John T Reeves
Venous occlusion plethysmography reduces arterial diameter and flow velocity.
Journal of applied physiology (Bethesda, Md. : 1985) 1989;66(5):2239-44.
1989: P A Ades; Eugene E Wolfel; William R Hiatt; C Fee; Robert Rolfs; H L Brammell; Lawrence D Horwitz
Exercise haemodynamic effects of beta-blockade and intrinsic sympathomimetic activity.
European journal of clinical pharmacology 1989;36(1):5-10.
1988: C Klein; William R Hiatt; John G Gerber; A S Nies
Age does not alter human vascular and nonvascular beta 2-adrenergic responses to isoproterenol.
Clinical pharmacology and therapeutics 1988;44(5):573-8.
1986: Eugene E Wolfel; William R Hiatt; H L Brammell; M R Carry; Steven P Ringel; V Travis; Lawrence D Horwitz
Effects of selective and nonselective beta-adrenergic blockade on mechanisms of exercise conditioning.
Circulation 1986;74(4):664-74.
1985: William R Hiatt; V L Travis; K B Horwitz; Lawrence D Horwitz
The effect of platelet protein and DNA on the measurement of human lymphocyte beta adrenergic receptor number.
Journal of receptor research 1985;5(5-6):419-29.
1985: William R Hiatt; Eugene E Wolfel; S Stoll; A S Nies; G O Zerbe; H L Brammell; Lawrence D Horwitz
beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol.
Clinical pharmacology and therapeutics 1985;37(1):2-6.
1984: William R Hiatt; R C Marsh; H L Brammell; C Fee; Lawrence D Horwitz
Effect of aerobic conditioning on the peripheral circulation during chronic beta-adrenergic blockade.
Journal of the American College of Cardiology 1984;4(5):958-63.
1983: R C Marsh; William R Hiatt; H L Brammell; Lawrence D Horwitz
Attenuation of exercise conditioning by low dose beta-adrenergic receptor blockade.
Journal of the American College of Cardiology 1983;2(3):551-6.